Trials / Completed
CompletedNCT01485328
Protocol: Phytomedicine-AMARGOL®, Clinical Trial for Efficacy Proof on Therapeutics
Phase III - Efficacy Study of AMARGOL - Phytomedicine on Therapeutics
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Laboratorio Saude Ltda. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a Phase 3: Efficacy Study for AMARGOL® a phytomedicine used for asymptomatic digestive complaints.
Detailed description
This study will be performed for proving the efficacy of AMARGOL®, a phytomedicine product, under the Brazilian law for registration and revalidation RDC 14/2010. AMARGOL® indications are for non specific digestive complaints as laxative and anti-dyspeptic. Is a mixture of 7 plant extracts: Aloe ferox, Angelica archangelica, Alpinia officinarum, Cinnamomum zeylanicum, Gentiana lutea, Commiphora myrrh and Rheum palmatum. Placebo controlled test
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AMARGOL® | per oral solution, 40 mL single dose |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2009-04-01
- Completion
- 2009-09-01
- First posted
- 2011-12-05
- Last updated
- 2011-12-06
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01485328. Inclusion in this directory is not an endorsement.